Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

Akihiko Asahina; Yukari Okubo; Akimichi Morita; Yayoi Tada; Atsuyuki Igarashi; Richard G. Langley; Delphine Deherder; Mizuho Matano; Veerle Vanvoorden; Maggie Wang; Mamitaro Ohtsuki; Hidemi Nakagawa

doi:10.1007/s13555-022-00883-y

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G. Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa

科研成果: 期刊稿件 › 文章 › 同行评审

7 引用（Scopus）

源语言	英语
页（从-至）	751-768
页数	18
期刊	Dermatology and Therapy
卷	13
期	3
DOI	https://doi.org/10.1007/s13555-022-00883-y
出版状态	已出版 - 3月 2023
已对外发布	是

!!!ASJC Scopus Subject Areas

皮肤医学

访问文件

10.1007/s13555-022-00883-y

其它文件与链接

引用此

Asahina, A., Okubo, Y., Morita, A., Tada, Y., Igarashi, A., Langley, R. G., Deherder, D., Matano, M., Vanvoorden, V., Wang, M., Ohtsuki, M., & Nakagawa, H. (2023). Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and Therapy, 13(3), 751-768. https://doi.org/10.1007/s13555-022-00883-y

Asahina, A, Okubo, Y, Morita, A, Tada, Y, Igarashi, A, Langley, RG, Deherder, D, Matano, M, Vanvoorden, V, Wang, M, Ohtsuki, M & Nakagawa, H 2023, 'Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study', Dermatology and Therapy, 卷 13, 号码 3, 页码 751-768. https://doi.org/10.1007/s13555-022-00883-y

@article{92997e756d044d1da7aa30e4e7ac3194,

title = "Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study",

keywords = "Absolute PASI, Active control, Bimekizumab, Japan subpopulation, Plaque psoriasis, Randomized controlled trial, Ustekinumab",

author = "Akihiko Asahina and Yukari Okubo and Akimichi Morita and Yayoi Tada and Atsuyuki Igarashi and Langley, {Richard G.} and Delphine Deherder and Mizuho Matano and Veerle Vanvoorden and Maggie Wang and Mamitaro Ohtsuki and Hidemi Nakagawa",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = mar,

doi = "10.1007/s13555-022-00883-y",

language = "English",

volume = "13",

pages = "751--768",

journal = "Dermatology and Therapy",

issn = "2193-8210",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID

T2 - A Phase 3, Ustekinumab and Placebo-Controlled Study

AU - Asahina, Akihiko

AU - Okubo, Yukari

AU - Morita, Akimichi

AU - Tada, Yayoi

AU - Igarashi, Atsuyuki

AU - Langley, Richard G.

AU - Deherder, Delphine

AU - Matano, Mizuho

AU - Vanvoorden, Veerle

AU - Wang, Maggie

AU - Ohtsuki, Mamitaro

AU - Nakagawa, Hidemi

PY - 2023/3

Y1 - 2023/3

KW - Absolute PASI

KW - Active control

KW - Bimekizumab

KW - Japan subpopulation

KW - Plaque psoriasis

KW - Randomized controlled trial

KW - Ustekinumab

UR - http://www.scopus.com/inward/record.url?scp=85146387870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146387870&partnerID=8YFLogxK

U2 - 10.1007/s13555-022-00883-y

DO - 10.1007/s13555-022-00883-y

M3 - Article

AN - SCOPUS:85146387870

SN - 2193-8210

VL - 13

SP - 751

EP - 768

JO - Dermatology and Therapy

JF - Dermatology and Therapy

IS - 3

ER -

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此